Search All UT System Experts

Zoledronic acid effectively prevents aromatase inhibitor- associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-fast study 36-month follow-up results

Adam M. Brufsky, Linda D. Bosserman, Richard R. Caradonna, Barbara B. Haley, C. Michael Jones, Halle C F Moore, Lixian Jin, Ghulam M. Warsi, Solveig G. Ericson, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

184 Scopus citations

Fingerprint

Dive into the research topics of 'Zoledronic acid effectively prevents aromatase inhibitor- associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-fast study 36-month follow-up results'. Together they form a unique fingerprint.

Medicine & Life Sciences